HPV vaccination: the beginning of the end of cervical cancer? - A Review. - Wikidata - awgldk - TriplyDB

HPV vaccination: the beginning of the end of cervical cancer? - A Review.

HPV vaccination: the beginning of the end of cervical cancer? - A Review.

http://www.wikidata.org/entity/Q37410888

about

Modelling the influence of climate on malaria occurrence in Chimoio Municipality, Mozambique.Use of cervicovaginal fluid for the identification of biomarkers for pathologies of the female genital tract.Cutaneous infections and infestations: new therapies Detection and Typing of Human Papilloma Viruses by Nested Multiplex Polymerase Chain Reaction Assay in Cervical Cancer.Risk factors associated with human papillomavirus infection in two populations from Rio de Janeiro, Brazil.Assessing protein stability of the dimeric DNA-binding domain of E2 human papillomavirus 18 with molecular dynamics.

P2860

Q33730492-A3454799-6D44-4046-8C2A-957F6AEA6FCC Q34467932-CBEF4D2C-B09C-4D72-8E0B-6769AF574129 Q35628618-A3C9FAA1-13B8-45DB-A824-F71D31F97450 Q36556464-04529F9D-BE79-432E-B563-6ACF5E4EE481 Q43252098-3F5FC7A4-5E78-4FD5-A129-4408ADCEFBB8 Q52600111-C01183B3-EEF7-4B80-915F-DFBBB7A99130

P2860

HPV vaccination: the beginning of the end of cervical cancer? - A Review.

http://www.wikidata.org/entity/Q37410888

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

HPV vaccination: the beginning of the end of cervical cancer? - A Review.

@en

HPV vaccination: the beginning of the end of cervical cancer? - A Review.

@nl

type

label

HPV vaccination: the beginning of the end of cervical cancer? - A Review.

@en

HPV vaccination: the beginning of the end of cervical cancer? - A Review.

@nl

prefLabel

HPV vaccination: the beginning of the end of cervical cancer? - A Review.

@en

HPV vaccination: the beginning of the end of cervical cancer? - A Review.

@nl

P1433

Q37410888-5B78E457-5CAF-42B7-98C4-86CFAFBE6A9A

P1476

Q37410888-76454956-9D2F-4E61-86CE-A56FC095C617

P2093

Q37410888-85E00A5C-D1DA-43EA-BB42-0F98E15CB218

Q37410888-FB9B4885-2322-4593-B64A-31B17E57C529

P2860

Q37410888-00B8C704-1E5E-4778-9AE2-2CD0C7DF1992

Q37410888-07AA9286-48F4-408A-927B-AD3B229DDE86

Q37410888-11770408-AE9C-40FA-B205-1E54A0545AD4

Q37410888-186083C9-6625-426A-BEFC-485095217B99

Q37410888-1D90B167-9FFF-4E7A-8318-791476D709E0

Q37410888-1EE9C449-C12B-4E5C-B720-22BD091DD093

Q37410888-2A46D7E1-38F1-4047-8BA4-8B78B68164D0

Q37410888-2B6ADD85-196F-47B2-8B79-20EEEE651A67

Q37410888-2DF734E4-ED2B-4E03-A053-F0A865FFC217

Q37410888-2F668633-4CDF-4702-B662-6A7BC03C29CE

P304

Q37410888-0817A8A1-F335-4B4E-A067-BC0AB2D5C0D9

P31

Q37410888-6C392CD1-8912-4A6C-9D74-27D68C6FEA1C

P356

Q37410888-1E0ABAE9-E0A2-4535-89FA-17B32DFB1900

P433

Q37410888-27F2305D-8C48-40E1-9F43-C477669780F4

P478

Q37410888-DE6C9E90-E4C3-4372-8D70-830792732B7B

P50

Q37410888-7EA2A010-5F92-4E41-AE70-DAE44483F4AF

P577

Q37410888-ADE547C4-B3AF-4B64-ABEC-B825FC1BDC6E

P698

Q37410888-9775CD59-4769-4DB1-99C0-EE92BB251B6E

P356

S0074-02762009000100001

P1433

Memórias do Instituto Oswaldo Cruz

P1476

HPV vaccination: the beginning of the end of cervical cancer? - A Review

@en

P2093

Luisa Lina Villa

http://www.w3.org/2001/XMLSchema#string

Tatiana Rabachini

http://www.w3.org/2001/XMLSchema#string

P2860

Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis

Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity

Induction of broad CD4+ and CD8+ T-cell responses and cross-neutralizing antibodies against hepatitis C virus by vaccination with Th1-adjuvanted polypeptides followed by defective alphaviral particles expressing envelope glycoproteins gpE1 and gpE2

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women

Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

Case-control study of human papillomavirus and oropharyngeal cancer

Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis

Chapter 28: Studies to assess the long-term efficacy and effectiveness of HPV vaccination in developed and developing countries.

P304

1-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/S0074-02762009000100001

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P50

Ana Paula Lepique

P577

2009-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19274369

http://www.w3.org/2001/XMLSchema#string